ITM2A and neoplasm: The downregulation of HLA-DQA1, HLA-DOB, and ITM2A, which are associated with immune evasion and tumor progression, is consistent with the immune-excluded phenotype observed in the mesenchymal-like (C5) and aggressive basal/squamous-like (C4) subtypes.